# Boston Scientific Corporation (BSX) — Q2-2017 Earnings Results

**Report date:** 2017-07-27 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q2-2017

## Post-Earnings Brief

### Headline

Boston Scientific Beats on EPS, Stock Down 1.35%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.32 | N/A | +2.84% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management remains positive about the company's direction despite some market challenges. They emphasized their commitment to innovation and growth.

**Key quotes:**

> Management highlighted ongoing product innovation as a key driver for future growth.

> They acknowledged challenges in certain markets but expressed confidence in their long-term strategy.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Boston Scientific's earnings report shows a slight beat on EPS, indicating better-than-expected profitability. However, the stock fell by 1.35%, likely due to a lack of revenue data and no guidance updates, which may have left investors uncertain about future performance. The company's focus on innovation suggests potential for growth, but market challenges remain a concern.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q2-2017_